Downstaging of Esophageal Cancer After Preoperative Radiation and Chemotherapy
- 1 June 1995
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 221 (6) , 685-695
- https://doi.org/10.1097/00000658-199506000-00008
Abstract
This retrospective, nonrandomized review evaluates 125 patients with esophageal carcinoma (adenocarcinoma and squamous cell) who underwent either surgery only or preoperative chemotherapy and/or radiation therapy followed by surgery. Major end points were survival and postchemoradiation downstaging. Forty-four patients underwent radiation therapy of 4500 cGy over 5 weeks. Fluorouracil and cisplatin were administered on the first and fifth week of radiotherapy. Ninety-eight patients underwent "potentially curative" resections-transhiatal esophagectomy (70), Lewis esophagogastrectomy (25), and left esophagogastrectomy (3). All patients with preoperative adjuvant therapy underwent endoscopy and biopsy before surgery. There were no differences in overall mortality (5%) or surgical complications in either group. Fourteen of 44 patients (32%) downstaged to complete pathologic response, with 5-year survival of 57%. Fifteen of 44 patients (34%) downstaged to microscopic residual tumor, with 1- and 3-year survival of 77% and 31%, respectively. Twenty-eight of 29 patients in the two downstaged groups were lymph node negative. Overall, 5-year survival in the adjuvant therapy plus surgery group versus surgery only was 36% and 11% (p = 0.04). Five-year survival in lymph node-negative adjuvant therapy and surgery patients was 49% (p = 0.005). Positive nodes in the surgery only group was 48% versus 23% in the adjuvant therapy and surgery group (p = 0.02). Although retrospective and nonrandomized, these results suggest that preoperative chemoradiation results in significant clinical and pathologic downstaging, increases survival, and may sterilize local and regional lymph nodes, accounting for both downstaging and survival statistics.Keywords
This publication has 18 references indexed in Scilit:
- Preoperative high-dose radiation and chemotherapy in adenocarcinoma of the esophagus and esophagogastric junctionAnnals of Surgical Oncology, 1994
- Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction.Journal of Clinical Oncology, 1990
- Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus.Journal of Clinical Oncology, 1990
- Ten-year follow-up of esophageal cancer treated by radical radiation therapy: analysis of 869 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Combined radiation and chemotherapy as primary management of adenocarcinoma of the esophagus and gastroesophageal junctionCancer, 1988
- Nonoperative therapy for squamous-cell cancer of the esophagus.Journal of Clinical Oncology, 1987
- Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: a potentially curative approach.Journal of Clinical Oncology, 1984
- Combined modality therapy for esophageal squamous cell carcinomaCancer, 1983
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977